(PRWEB) April 25, 2005
Once again, another Cox-2 inhibitor is pulled off the market by the Food and Drug Administration, and the Bextra Legal Group is helping to guide former consumers of the drug in the right direction with regards to their damage claims.
John Lee, of the Bextra Legal Group said in a recent statement: "The effects that the pharmaceutical companies have on the consumer population is astounding. It's also very disturbing to know that they don't conduct proper research concerning the effects a drug will have, before releasing their drugs onto the market. It's almost as if they consider it a calculated risk. That's fine with us, because when it starts costing them money in damages from consumer class action suits, they'll perk up and pay attention to the risks being introduced with their drugs before they introduce them."
The Bextra Legal Group is positioned to help consumers with damage claims now, and into the future as conditions deteriorate or improve depending on depending on the FDA's position toward the pharmaceutical drug industry.
This recent blow to Pfizer's "super drug", Bextra, follows the recent series of FDA developments against Cox-2 inhibitor type drugs, such as Merck's Vioxx which was also recently yanked off the market. Although the Vioxx recall was voluntary, as damage claims against Merck have mounted, it can be assumed that the drug was next on the FDA's "hit" list, if Merck didn't recall it voluntarily. It can also be assumed that Vioxx, and Bextra were not the last drugs to get "pulled" off the market, but as it happens the Florida Legal Group will be here to help.
About The Bextra Legal Group
The Bextra Legal Group was created for individuals who have possible claims against Pfizer for damages caused by Bextra (Valdecoxib). Part of the Vioxx Legal Group that helped consumers fight against Merck a few months ago, and currently, the new Bextra Legal Group expects to help in the same way the popular Vioxx Legal Group has done.
For additional information, visit:
# # #